| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 0 | 0 | 0 | 7.630 | 98.717 | 183.841 |
| Total Income - EUR | - | - | 0 | 800 | 11.116 | 7.968 | 7.630 | 18.949 | 274.604 | 390.665 |
| Total Expenses - EUR | - | - | 7.171 | 15.340 | 23.272 | 23.267 | 39.453 | 142.905 | 266.749 | 380.059 |
| Gross Profit/Loss - EUR | - | - | -7.171 | -14.540 | -12.156 | -15.299 | -31.822 | -123.956 | 7.855 | 10.606 |
| Net Profit/Loss - EUR | - | - | -7.171 | -14.555 | -12.389 | -15.318 | -31.822 | -124.032 | 6.873 | 2.929 |
| Employees | - | - | 1 | 1 | 1 | 1 | 1 | 2 | 6 | 6 |
Check the financial reports for the company - Biosere Eforie Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 6.399 | 6.282 | 834.347 | 1.797.288 | 2.019.350 | 2.240.328 | 2.256.850 | 2.065.727 |
| Current Assets | - | - | 1.171 | 2.381.994 | 1.557.019 | 482.222 | 170.412 | 148.441 | 223.462 | 337.102 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 13.563 | 70.146 | 58.011 |
| Receivables | - | - | 0 | 1.522.964 | 1.556.602 | 269.525 | 119.268 | 130.303 | 147.837 | 30.431 |
| Cash | - | - | 1.171 | 859.030 | 417 | 212.697 | 51.144 | 4.574 | 5.479 | 248.660 |
| Shareholders Funds | - | - | -7.127 | -21.552 | -33.524 | -48.206 | -78.960 | -203.237 | -178.373 | -173.090 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 15.509 | 490.217 | 542.257 | 485.824 | 475.487 | 804.297 | 988.728 | 1.112.340 |
| Income in Advance | - | - | 0 | 1.920.493 | 1.883.300 | 1.842.796 | 1.794.300 | 1.788.772 | 1.672.043 | 1.466.079 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "113 - 113" | |||||||||
| CAEN Financial Year |
113
|
|||||||||
Comments - Biosere Eforie Srl